HEALTH WIRE  /  Depression desk Filed as evergreen · Reviewed for accuracy Coverage: Missouri & the Greater Midwest
Vol. VIISt. Charles County desk
Reader-supported
TheMidwest HealthDispatch
Mental health desk
Info, not adviceVerified against public sources

From our survey

Myths that keep Midwest veterans from the first appointment

For a lot of veterans, the gap between knowing something is wrong and walking into a doctor's office is enormous. That gap tends to fill with beliefs that sound reasonable and turn out to be wrong. Some come from service culture. Some come from bad experiences. Some come from the internet.

Here are seven that keep veterans across the Midwest away from depression care, checked against the facts. Some of the checks lean on a survey we paid to run, which 443 adults across ten Midwest states completed. Its sample was the general public, so each figure describes all respondents rather than veterans, who were too few to report alone, and each is final now that Pollfish has validated the panel.

Myth 1: "I should figure this out myself before I bother a doctor"

False. Most people do the opposite, and for good reason. Our survey asked people to name a first stop for new depression treatment, and primary doctors won at 56 percent. Psychiatrists took 23 percent, and online searching trailed at 12 percent.

Research online can feel productive without moving you any closer to care. People type things like "ptsd help," "how to overcome depression," and "someone please help me." Those searches lead to ads and forums. A doctor can do in one visit what weeks of searching cannot: look at your history and tell you what fits.

Myth 2: "I need a veterans-only program before I can get real help"

False. Every primary care doctor is trained to assess depression and begin treatment or a referral. Many veterans in the Midwest get their care through an employer plan, Medicare, Medicaid, or TRICARE, from the same doctors their neighbors see. Specialized programs can be valuable, but waiting to find the perfect one can mean months without care. Start with the doctor you can see this month, and tell them you served.

It is also fair to ask a new doctor, "How much experience do you have with patients who served?" A good one will answer honestly. If they think a specialist would serve you better, they can make that referral, and you will already be moving.

Myth 3: "Asking for help will wreck my career or my clearance"

Mostly false. This fear keeps many service members and veterans in federal jobs quiet. Federal security clearance guidance has stated for years that seeking mental health care, on its own, is not a reason to deny or revoke a clearance. Many clearance holders get treatment and keep their clearances. Specifics vary, so if you serve now or hold a clearance, check with your security office or a behavioral health provider about your own case. Left untreated, problems tend to cause more career trouble than treated ones.

Myth 4: "Other vets online are the best guide"

Half true. Peer stories can be powerful. They make you feel less alone and can give you the push to act. But they are not a treatment plan. In our survey, an online veteran or first responder they follow would move just 4 percent of respondents toward a new treatment. A person's own doctor would sway 74 percent.

Use peers for courage. Use a doctor for decisions.

Myth 5: "If the meds didn't work, nothing will"

False. Depression that shrugs off standard medication is common. Our survey found that 72 percent had faced, directly or through someone close, depression, anxiety, or PTSD that usual medicines did not help. You are not an unusual case, and there are other options.

Esketamine, which carries the Spravato brand name, is FDA-approved for depression where standard treatment came up short. Certified clinics administer it and keep watch for two hours or more; Brain Recovery Centers describes how a Spravato visit unfolds. TMS is an FDA-cleared treatment that uses magnetic stimulation and no medication. For PTSD, trauma-focused approaches like cognitive processing therapy and prolonged exposure are well researched. None is certain to work, and a clinician decides what fits. But "nothing else exists" is simply not true.

Myth 6: "At-home ketamine is the same thing a clinic offers"

False. This one matters because at-home ketamine is heavily advertised to veterans. Esketamine at a certified clinic is FDA-approved for depression and given under supervision. Ketamine products used at home are often compounded and are not FDA-approved for depression. Federal regulators have cautioned that compounded ketamine taken without medical monitoring carries real risks. Esketamine's approval is also for depression, not PTSD. If a company tells you otherwise, be skeptical.

Myth 7: "I'm too far from anything for this to be realistic"

Sometimes true, often fixable. Distance is a real barrier across the rural Midwest. Being close to home was a top-two priority for 43 percent of our respondents. Some treatments need frequent visits, and with esketamine you need a ride home every time.

But distance has workarounds. Therapy and medication follow-ups can often happen by video. Community mental health centers operate in many rural counties, and many of them see patients whether or not they can pay. And your first doctor can tell you what is closest, which is often more useful than what is most famous.

What actually gets you started

Consider this general information, not medical advice. Picking a treatment belongs to you and your clinician, with your full history on the table.

When suicidal thoughts are part of the picture, act today instead of waiting on an appointment. Reach 988 by call or text. Veterans on that line can press 1. You will reach a trained counselor, confidentially.

Methodology

Pollfish's consumer panel carried this myth-check survey to its June 23, 2026 close, gathering 443 completions from adults 18 to 64 in Wisconsin, Nebraska, Indiana, Ohio, Iowa, Minnesota, Kansas, Missouri, Oklahoma, and Illinois. It was not limited to veterans, and every figure is final after panel validation. Disclosure: the publisher commissioned this study and paid for it.